Morgan Stanley Maintains Overweight on Eli Lilly, Raises Price Target to $1596

Benzinga · 2d ago
Morgan Stanley analyst Terence Flynn maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $1430 to $1596.